Home-based brain stimulation is reshaping care for mild cognitive impairment. Emerging evidence shows that caregiver-administered tACS can deliver safe, scalable, and repeatable neuromodulation at home—opening new opportunities to improve adherence, accessibility, and long-term cognitive outcomes beyond the clinic.

Emerging evidence suggests that precision multichannel tDCS—guided by electric-field optimization—can deliver faster and stronger antidepressant effects than conventional approaches, reinforcing findings from earlier home-based studies.

Rapid EEG enables quick brain monitoring in the emergency room, allowing clinicians to make faster, more informed decisions when every second counts.